source
- Western pharma firms lobby Trump administration to preserve China partnership opportunitiesWestern pharmaceutical companies are urging the Trump administration to permit continued collaborations with Chinese firms on promising drug candidates, despite a 2025 law that limits U.S. investme…
- Federal AI Initiative Aims to Improve Chronic Heart Failure Care, Pending Doctor and Patient AcceptanceA new federal program will test artificial‑intelligence tools in the management of chronic heart‑failure patients. The initiative is designed to explore how AI can support diagnosis, monitoring and…